Vall d'Hebron Institut de Recerca-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2022

  1. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

2021

  1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

2008

  1. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice

    Journal of Neurochemistry, Vol. 107, Núm. 4, pp. 1102-1112